Anecortave acetate is a synthetic angiostatic agent designed as a derivative of cortisol, primarily utilized in research related to the treatment of exudative age-related macular degeneration. As a cortisene,… Read more
![Chemical structure of (8R,9S,10R,13S,14S,17R)-17-(2-Acetoxyacetyl)-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl propionate;](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F8R9S10R13S14S17R-17-2-Acetoxyacetyl-1013-dimethyl-3-oxo-2367891011121314151617-tetradecahydro-1H-cyclopentaaphenanthren-17-yl-propionate.png&w=3840&q=75)









Anecortave acetate is a synthetic angiostatic agent designed as a derivative of cortisol, primarily utilized in research related to the treatment of exudative age-related macular degeneration. As a cortisene, it acts to inhibit ocular neovascularization by regulating vascular endothelial cell processes rather than through typical glucocorticoid pathways. This category includes a specialized selection of reference standards, including pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds. These high-purity materials are essential for pharmaceutical laboratories performing rigorous impurity profiling, method validation, and quantitative analysis. Researchers rely on these standards to accurately detect, monitor, and quantify potential degradation products and synthetic by-products throughout the drug development and quality control lifecycle. The inclusion of stable isotope-labelled variants provides critical support for mass spectrometry-based testing, ensuring precision and reliability in analytical stability studies and routine quality assessment.